Table 1 Demographic characteristics of CancerCostMod for all cancers combined, and most commonly diagnosed cancers^a

Actual n

25,600

3100

4200

2900

2100

3300

Weighted N (%)

123,900

15,400 (12.5)

20,700 (16.7)

14,800 (11.9)

11,100 (9.0)

12,300 (9.9)

Died within 12-months post-diagnosis (%)

25,100 (20.2)

700 (4.2)

1000 (4.6)

2400 (16.3)

6400 (57.7)

400 (3.1)

  ≤ 17 (%)

1000 (0.8)

–

–

–

–

–

 18 to 44 (%)

9300 (7.5)

1800 (12.0)

100 (0.6)

700 (4.7)

200 (1.6)

1800 (14.6)

 45 to 64 (%)

42,700 (34.5)

7600 (49.1)

7800 (37.7)

4100 (27.7)

2900 (26.3)

4500 (36.4)

  ≥ 65 (%)

70,900 (57.2)

6000 (38.9)

12,800 (61.8)

10,000 (27.6)

8000 (72.1)

6000 (48.7)

 Male (%)

69,300 (55.9)

100 (0.7)

20,700 (100)

8100 (54.9)

6500 (58.4)

7200 (58.4)

 Female (%)

54,600 (44.1)

15,300 (99.3)

n/a

6700 (45.1)

4600 (41.6)

5100 (41.6)

 Non-Indigenous Australian (%)

121,800 (98.3)

15,200 (98.4)

20,500 (99.0)

14,600 (99.1)

10,800 (97.3)

12,100 (98.8)

 Indigenous Australian (%)

2100 (1.7)

300 (1.6)

200 (1.0)

100 (0.9)

300 (2.7)

100 (1.2)

 Metropolitan (%)

58,500 (47.5)

7800 (50.5)

9100 (44.1)

6700 (45.9)

5000 (45.2)

6100 (49.7)

 Regional (%)

54,500 (44.2)

6400 (41.7)

9600 (46.5)

6600 (45.1)

5100 (45.8)

5300 (43.7)

 Remote (%)

10,200 (8.3)

1200 (7.8)

1900 (9.4)

1300 (9.1)

1000 (9.0)

800 (6.7)

 Q1 (Most disadvantaged) (%)

11,300 (9.2)

1100 (7.2)

2100 (10.2)

1400 (9.8)

1300 (11.6)

1000 (8.2)

 Q2 (%)

5700 (4.7)

800 (5.0)

900 (4.3)

700 (4.6)

600 (5.3)

500 (4.3)

 Q3 (%)

19,900 (16.2)

2500 (16.3)

3400 (16.5)

2500 (16.7)

1900 (17.5)

1800 (14.7)

 Q4 (%)

56,000 (45.5)

6700 (43.7)

9300 (45.2)

6700 (45.7)

4900 (44.5)

5900 (47.9)

 Q5 (Least disadvantaged) (%)

30,200 (24.5)

4300 (27.8)

4900 (23.8)

3400 (23.1)

2300 (21.1)

3000 (24.9)